3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Sponsor
Interventions
pembrolizumab
38
Specimen Handling
37
Magnetic Resonance Spectroscopy
26
Biopsy
26
Cyclophosphamide
25
Carboplatin
25
fludarabine
21
Nivolumab
20
Gemcitabine
18
Dexamethasone
18
Paclitaxel
15
Rituximab
13
Bevacizumab
13
Pemetrexed
12
Docetaxel
12
atezolizumab
11
Cisplatin
11
Lenalidomide
10
Ipilimumab
10
Fulvestrant
10
venetoclax
9
Prednisone
9
Oxaliplatin
9
olaparib
8
fludarabine phosphate
8
belantamab mafodotin
8
Temozolomide
8
Injections
8
Fluorouracil
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Phase 1/2
×
CVAD protocol
×
30 days
×
Clear all
No trials found.